羚锐制药：大股东338万股股份解除质押，剩余质押占总股本5%

Core Viewpoint - Lingrui Pharmaceutical announced that its major shareholder, Lingrui Group, will release the pledge of 3.38 million shares on November 20, 2025, which accounts for 2.77% of its holdings and 0.60% of the company's total share capital [1] Summary by Relevant Sections - Shareholding Structure - Lingrui Group holds a total of 121,817,898 shares, representing 21.48% of the total share capital of the company [1] - Pledge Details - After the release of the pledge, Lingrui Group will have a total of 28,350,000 shares pledged, which is 23.27% of its holdings and 5.00% of the company's total share capital [1] - As of the announcement date, Lingrui Group and its concerted parties have a total of 28,350,000 shares pledged, accounting for 22.18% of their combined holdings and 5.00% of the company's total share capital [1] - Future Pledge Plans - Lingrui Group has no plans for subsequent pledges of the released shares [1]